Mammalian Manufacturing Solutions

With over 40 years of cGMP contract manufacturing experience and more than 700 successful regulatory inspections in the past five years, Novartis Contract Manufacturing offers unmatched expertise and global reach.

Our integrated network spans more than 20 manufacturing sites across Europe and Asia, delivering scalable, high-quality solutions for mammalian cell-based production—from process development to commercial supply. Our services include working cell bank production, fed-batch and perfusion capabilities, advanced analytical testing, bioassays, environmental monitoring, and comparability studies. Facilities are equipped with cutting-edge stainless steel and single-use bioreactors ranging from pilot to large scale, supporting flexible production strategies including continuous perfusion manufacturing. Discover how our deep experience in therapeutic proteins, monoclonal and multispecific antibodies, and enzymes enables us to deliver end-to-end solutions that adapt to your program’s evolving needs.